Molecular and Clinical Oncology · 2019 · 36 citations · 23 references
Life SciencesMolecular BiologyOncologyApoptosisGenome EditingMolecular OncologyCrispr-cas SystemsRna InterferenceTargeted Cancer TherapyTherapeutic Genome EditingCrispr-cas9 Genome EditingCrispr-cas9 KnockoutG1 Phase ArrestG1-s Phase TransitionG1-s Transition ControlG1/s TransitionG2 Phase ProgressionMalignant Melanocytic Tumors
Cutaneous melanoma is one of the most common malignant skin tumors, with a continuously increasing incidence. Cyclin-dependent kinase (CDK) 2 is a key regulator of G1-S transition and modulation of G2 progression; however, its role in cancer is a matter of debate. In the present study, a lentivirus expressing single-guide RNA (sgRNA) was constructed to knock out CDK2 using CRISP/Cas9 technology, in order to confirm the role of CDK2 in A375 human melanoma cells. The results demonstrated that CDK2 knockout induced G0/G1 phase arrest and early apoptosis by downregulating the expression of CDK4 and cyclin A2, and by upregulating the expression of cyclin D1. These results suggest that therapeutic strategies designed to target CDK2 using CRISP/Cas9 may improve the treatment outcome of cutaneous melanoma.
23
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem, Neville E. Sanjana, Ella Hartenian et al. · Science · 2013 · 5.5K citations · Full text
Cyril Berthet, Eiman Aleem, Vincenzo Coppola et al. · Current Biology · 2003 · 657 citations · Full text